A randomized controlled phase III trial of recombinant human G-CSF in treatment of patients with severe chronic neutropenia
Document Type
Journal Article
Role
Author
Published In
Blood
Volume
81
First Page
2496
Last Page
2502
Publication Date
1993
Suggested Citation
Dale, David C., et al. "A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia." Blood 81.10 (1993): 2496-2502.
